Earlier this year, Tagline carried a story about “desktop sequencing” based on Ion Torrent’s semi-conductor approach which detects DNA [MORE]
Life Technologies, Inc. (Carlsbad, CA)-formed from a 2008 merger of Invitrogen Corporation and Applied Biosystems-has reached an agreement with [MORE]
Recently, Ion Torrent (Guilford, CT, a branch of Life Technologies-formerly Applied Biosciences) named Ambry Genetics (Aliso Viego, CA) as [MORE]
In 1955, the National Cancer Institute began organizing oncologists into regional study groups to address specific interests that NCI [MORE]
Suppose an outbreak of a new antibiotic- resistant pathogen appeared in one place and then another, and onward from [MORE]
A rap against consumer genomics has been the lack of interpreting authority-e.g. what does a 30% increase in risk [MORE]
Surviving cancer can have adverse effects-e.g. cardiovascular complications, obesity, diabetes, osteopenia and osteoporosis, et al. For those reasons, cancer [MORE]
In January, Stephen Kingsmore, chief scientific officer for the National Human Genome Research Institute, reported that he and his [MORE]
It has happened before, and often: scientific discovery running ahead of medical practice and public policy, with consumer demand [MORE]
Last year, an FDA report about the superficiality of personalized genomics tests forestalled drug stores selling those kits. Two [MORE]
Researchers at the University of California, San Diego and the Scripps Research Institute recently made a disturbing discovery [MORE]
Oncotype DX is a “companion diagnostic” for women with early stage breast cancer who might be treated with hormone [MORE]
In poor countries, where tuberculosis ravages, the standard technique for detection is a sputum slide under a microscope. But [MORE]
Thoroughbred race horse breeders have long observed what they call the “grand sire” effect-where the immediate offspring of a [MORE]
It has been 10 years since the publication of the first draft of the sequence of the human genome. This [MORE]
To read this interview with Daniel Gibson, a molecular biologist with the J. Craig Venter Institute (Rockville, MD and San [MORE]
The breakthroughs in molecular medicine open new vistas for health, but before this translates into healthcare, astute physicians must [MORE]
This past summer, life sciences instrument maker Illumina, Inc. (San Diego, CA) announced its founding of a collaboration [MORE]
Most tests for genetic diseases seek a single mutation or observable chromosome abnormality. Chromosomal microarrays, by comparison, reveal copy [MORE]
Affymetrix, Cell Therapy News, Genome…MORE